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To a stirred, cooled (0 °C) solution of N-ferrocenylphthalimide (1.66 g, 5.0 mmol) in CH 2 Cl 2 (15 mL) was added hydrazine monohydrate (2.50 g, 50.0 mmol). The reaction was stirred for 1 h at room temperature and then filtered on celite ® . The filtrate was dried over MgSO 4 
3-Amino-3-deoxy-N-(tert-butoxycarbonyl)-1,2-O-isopropylidene-α-D-ribofuranoic acid (SAA-1).

Methyl 3-amino-3-deoxy-N-(tert-butoxycarbonyl)-1,2-O-isopropylidene-α-D-ribofuranoate
Ferrocene Carboxamide FcC-2.
FcC-2 was prepared from aminoferrocene (1) and SAA-2 according to the general procedure for peptidic coupling. Purification by flash chromatography on silica gel (EtOAc/CH 2 Cl 2 : 1/9) gave FcC-2
S5
(292 g, 60%) as a yellow solid (mp = 242 °C).
[α] D (20 °C) = -6.5 (c 1.6, CHCl 3 The 1 H NMR spectra is as described previously. 
2-Iodoferrocenecarboxylic acid (racemic mixture) (rac-7).
To a stirred, cooled (0 °C) solution of racemic methyl 2-iodoferrocenecarboxylate 7 
(S P )-2-Iodoferrocenecarboxylic acid (S P -7).
To a stirred, cooled (0 °C) solution of (S P )-3-O-(2-iodoferrocenecarbonyl)-1,2:5,6-di-Oisopropylidene-α-D-glucofuranose
(S P )-N-(Ethoxycarbonylmethyl)-2-iodoferrocenecarboxamide (S P -8).
S P -8 was prepared from S P -7 and H-Gly-OEt·HCl according to the general procedure for peptidic 
2-(Tert-butoxycarbonylamino)ethyl 2-iodoferrocenecarboxylate (racemic mixture) (rac-10).
To a stirred, cooled ( with Tris-EDTA buffer. Color intensity was measured in an ELISA reader, and the relation between surviving fraction and drug concentration is plotted to get the survival curve of the tumor cell line after the specified compound and the IC 50 was calculated.
